Physician profile
Heather Griffith
NPI 1508205519
$2,736.91
in general payments reported to CMS, 2019-2025
31 companies · $712 in 2025
The $712 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $308 · 2023: $335 · 2024: $918 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $510.64 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $278.43 | 2021-2025 | |
| Pfizer INC. | $227.09 | 2021-2024 | |
| Lilly USA, LLC | $179.11 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $177.60 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $163.93 | 2022-2025 | Freestyle Libre 3, Eterna |
| Amgen INC. | $155.61 | 2021-2025 | Evenity, Prolia, Prolia |
| Glaxosmithkline, LLC. | $105.10 | 2021-2025 | Trelegy Ellipta |
| Shield Therapeutics INC | $103.92 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.77 | 2021-2025 | Jardiance |
| Daiichi Sankyo INC. | $84.74 | 2021-2023 | Injectafer |
| Philips North America LLC | $80.39 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Verona Pharma, INC. | $62.50 | 2025 | Ohtuvayre |
| Phathom Pharmaceuticals, INC. | $60.26 | 2024-2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $56.63 | 2023-2024 | Keveyis |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $49.61 | 2023-2024 | Vivitrol, Vivitrol |
| Astrazeneca Pharmaceuticals LP | $46.98 | 2024-2025 | Breztri |
| Merck Sharp & Dohme LLC | $42.51 | 2021-2022 | |
| Sobi, INC | $32.96 | 2021 | |
| Amarin Pharma, INC. | $31.20 | 2021 | |
| Astellas Pharma US INC | $29.16 | 2021-2023 | Veozah |
| Janssen Pharmaceuticals, INC | $20.79 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.28 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $18.62 | 2022 | |
| Biogen, INC. | $18.32 | 2023 | Spinraza |
| Inspire Medical Systems, INC. | $17.17 | 2025 | Inspire |
| Stryker Corporation | $16.43 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biohaven Pharmaceuticals, INC. | $16.16 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.06 | 2021 | |
| Currax Pharmaceuticals LLC | $14.22 | 2025 | Onzetra Xsail, Contrave |
| Allergan, INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.